Works matching IS 15228517 AND DT 2021 AND VI 23 AND IP 8

Results: 31
    1
    2
    3
    4

    Forthcoming Meetings.

    Published in:
    Neuro-Oncology, 2021, v. 23, n. 8, p. 1416, doi. 10.1093/neuonc/noab148
    Publication type:
    Article
    5
    6

    Report of National Brain Tumor Society roundtable workshop on innovating brain tumor clinical trials: building on lessons learned from COVID-19 experience.

    Published in:
    Neuro-Oncology, 2021, v. 23, n. 8, p. 1252, doi. 10.1093/neuonc/noab082
    By:
    • Lee, Eudocia Q;
    • Selig, Wendy;
    • Meehan, Clair;
    • Bacha, Jeffrey;
    • Barone, Amy;
    • Bloomquist, Erik;
    • Chang, Susan M;
    • Groot, John F de;
    • Galanis, Evanthia;
    • Hassan, Islam;
    • Kalidas, Chitkala;
    • Khasraw, Mustafa;
    • Kvedar, Joseph C;
    • Lassman, Andrew B;
    • Puduvalli, Vinay;
    • Sahebjam, Solmaz;
    • Schwamm, Lee H;
    • Tamir, Sharon;
    • Welch, Mary;
    • Yung, W K Alfred
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13

    The 2021 WHO Classification of Tumors of the Central Nervous System: a summary.

    Published in:
    Neuro-Oncology, 2021, v. 23, n. 8, p. 1231, doi. 10.1093/neuonc/noab106
    By:
    • Louis, David N;
    • Perry, Arie;
    • Wesseling, Pieter;
    • Brat, Daniel J;
    • Cree, Ian A;
    • Figarella-Branger, Dominique;
    • Hawkins, Cynthia;
    • Ng, H K;
    • Pfister, Stefan M;
    • Reifenberger, Guido;
    • Soffietti, Riccardo;
    • Deimling, Andreas von;
    • Ellison, David W
    Publication type:
    Article
    14
    15
    16
    17

    Height in adolescence as a risk factor for glioma subtypes: a nationwide retrospective cohort study of 2.2 million subjects.

    Published in:
    Neuro-Oncology, 2021, v. 23, n. 8, p. 1383, doi. 10.1093/neuonc/noab049
    By:
    • Tschernichovsky, Roi;
    • Katz, Lior H;
    • Derazne, Estela;
    • Berliner, Matan Ben-Zion;
    • Simchoni, Maya;
    • Levine, Hagai;
    • Keinan-Boker, Lital;
    • Benouaich-Amiel, Alexandra;
    • Kanner, Andrew A;
    • Laviv, Yosef;
    • Honig, Asaf;
    • Dudnik, Elizabeth;
    • Siegal, Tali;
    • Mandel, Jacob;
    • Twig, Gilad;
    • Yust-Katz, Shlomit
    Publication type:
    Article
    18

    Reply to letter by Schwartz et al.

    Published in:
    Neuro-Oncology, 2021, v. 23, n. 8, p. 1406, doi. 10.1093/neuonc/noab078
    By:
    • Kuksis, Markus;
    • Gao, Yizhuo;
    • Kiss, Alex;
    • Jerzak, Katarzyna J
    Publication type:
    Article
    19

    DNA methylation-based signatures classify sporadic pituitary tumors according to clinicopathological features.

    Published in:
    Neuro-Oncology, 2021, v. 23, n. 8, p. 1292, doi. 10.1093/neuonc/noab044
    By:
    • Mosella, Maritza S;
    • Sabedot, Thais S;
    • Silva, Tiago C;
    • Malta, Tathiane M;
    • Dezem, Felipe Segato;
    • Asmaro, Karam P;
    • Wells, Michael;
    • Mukherjee, Abir;
    • Poisson, Laila M;
    • Snyder, James;
    • deCarvalho, Ana C;
    • Walbert, Tobias;
    • Aho, Todd;
    • Kalkanis, Steven;
    • Elias, Paula C;
    • Antonini, Sonir R;
    • Rock, Jack;
    • Noushmehr, Houtan;
    • Castro, Margaret;
    • Castro, Ana Valeria
    Publication type:
    Article
    20

    A prospective phase II randomized trial of proton radiotherapy vs intensity-modulated radiotherapy for patients with newly diagnosed glioblastoma.

    Published in:
    Neuro-Oncology, 2021, v. 23, n. 8, p. 1337, doi. 10.1093/neuonc/noab040
    By:
    • Brown, Paul D;
    • Chung, Caroline;
    • Liu, Diane D;
    • McAvoy, Sarah;
    • Grosshans, David;
    • Feghali, Karine Al;
    • Mahajan, Anita;
    • Li, Jing;
    • McGovern, Susan L;
    • McAleer, Mary-Fran;
    • Ghia, Amol J;
    • Sulman, Erik P;
    • Penas-Prado, Marta;
    • Groot, John F de;
    • Heimberger, Amy B;
    • Wang, Jihong;
    • Armstrong, Terri S;
    • Gilbert, Mark R;
    • Guha-Thakurta, Nandita;
    • Wefel, Jeffrey S
    Publication type:
    Article
    21
    22

    Loss of H3K27me3 in meningiomas.

    Published in:
    Neuro-Oncology, 2021, v. 23, n. 8, p. 1282, doi. 10.1093/neuonc/noab036
    By:
    • Nassiri, Farshad;
    • Wang, Justin Z;
    • Singh, Olivia;
    • Karimi, Shirin;
    • Dalcourt, Tatyana;
    • Ijad, Nazanin;
    • Pirouzmand, Neda;
    • Ng, Ho-Keung;
    • Saladino, Andrea;
    • Pollo, Bianca;
    • Dimeco, Francesco;
    • Yip, Stephen;
    • Gao, Andrew;
    • Aldape, Kenneth D;
    • Zadeh, Gelareh;
    • Meningiomas, The International Consortium on
    Publication type:
    Article
    23

    Ultra high-risk PFA ependymoma is characterized by loss of chromosome 6q.

    Published in:
    Neuro-Oncology, 2021, v. 23, n. 8, p. 1360, doi. 10.1093/neuonc/noab034
    By:
    • Baroni, Lorena V;
    • Sundaresan, Lakshmikirupa;
    • Heled, Ayala;
    • Coltin, Hallie;
    • Pajtler, Kristian W;
    • Lin, Tong;
    • Merchant, Thomas E;
    • McLendon, Roger;
    • Faria, Claudia;
    • Buntine, Molly;
    • White, Christine L;
    • Pfister, Stefan M;
    • Gilbert, Mark R;
    • Armstrong, Terri S;
    • Bouffet, Eric;
    • Kumar, Sachin;
    • Taylor, Michael D;
    • Aldape, Kenneth D;
    • Ellison, David W;
    • Gottardo, Nicholas G
    Publication type:
    Article
    24

    Neurocognitive functioning and radiologic changes in primary CNS lymphoma patients: results from the HOVON 105/ALLG NHL 24 randomized controlled trial.

    Published in:
    Neuro-Oncology, 2021, v. 23, n. 8, p. 1315, doi. 10.1093/neuonc/noab021
    By:
    • van der Meulen, Matthijs;
    • Dirven, Linda;
    • Habets, Esther J J;
    • Bakunina, Katerina;
    • Smits, Marion;
    • Achterberg, Hakim C;
    • Seute, Tatjana;
    • Cull, Gavin;
    • Schouten, Harry;
    • Zijlstra, Josée M;
    • Brandsma, Dieta;
    • Enting, Roelien H;
    • Beijert, Max;
    • Taphoorn, Martin J B;
    • Bent, Martin J van den;
    • Issa, Samar;
    • Doorduijn, Jeanette K;
    • Bromberg, Jacoline E C
    Publication type:
    Article
    25
    26

    Therapeutic targeting of transcriptional elongation in diffuse intrinsic pontine glioma.

    Published in:
    Neuro-Oncology, 2021, v. 23, n. 8, p. 1348, doi. 10.1093/neuonc/noab009
    By:
    • Katagi, Hiroaki;
    • Takata, Nozomu;
    • Aoi, Yuki;
    • Zhang, Yongzhan;
    • Rendleman, Emily J;
    • Blyth, Gavin T;
    • Eckerdt, Frank D;
    • Tomita, Yusuke;
    • Sasaki, Takahiro;
    • Saratsis, Amanda M;
    • Kondo, Akihide;
    • Goldman, Stewart;
    • Becher, Oren J;
    • Smith, Edwin;
    • Zou, Lihua;
    • Shilatifard, Ali;
    • Hashizume, Rintaro
    Publication type:
    Article
    27
    28

    Corrigendum to INTELLANCE 2/EORTC 1410 randomized phase II study of Depatux-M alone and with temozolomide vs temozolomide or lomustine in recurrent EGFR amplified glioblastoma.

    Published in:
    Neuro-Oncology, 2021, v. 23, n. 8, p. 1415, doi. 10.1093/neuonc/noaa115
    By:
    • van den Bent, Martin;
    • Eoli, Marica;
    • Sepulveda, Juan Manuel;
    • Smits, Marion;
    • Walenkamp, Annemiek;
    • Frenel, Jean-Sebastian;
    • Franceschi, Enrico;
    • Clement, Paul M;
    • Chinot, Olivier;
    • Vos, Filip de;
    • Whenham, Nicolas;
    • Sanghera, Paul;
    • Weller, Michael;
    • Dubbink, H J;
    • French, Pim;
    • Looman, Jim;
    • Dey, Jyotirmoy;
    • Krause, Scott;
    • Ansell, Pete;
    • Nuyens, Sarah
    Publication type:
    Article
    29

    Erratum to 'Connexin43 peptide, TAT-Cx43<sub>266–283</sub>, selectively targets glioma cells, impairs malignant growth, and enhances survival in mouse models in vivo'.

    Published in:
    Neuro-Oncology, 2021, v. 23, n. 8, p. 1414, doi. 10.1093/neuonc/noaa087
    By:
    • Jaraíz-Rodríguez, Myriam;
    • Talaverón, Rocío;
    • García-Vicente, Laura;
    • Pelaz, Sara G;
    • Domínguez-Prieto, Marta;
    • Álvarez-Vázquez, Andrea;
    • Flores-Hernández, Raquel;
    • Sin, Wun Chey;
    • Bechberger, John;
    • Medina, José M;
    • Naus, Christian C;
    • Tabernero, Arantxa
    Publication type:
    Article
    30
    31